On Nov. 8, a new patent application filed with the U.S. Patent and Trade mark office revealed that U.S. multinational IT company IBM plans to use blockchain to aid scientific research and provide a record of its results.
IBM, originally filing the concept in December last year, says it anticipates” integrating a blockchain and data collection and analysis for open scientific research.”
The most recent award coming last week targeted at augmented reality gaming. The application is the latest in a steadily increasing pile of patents sought by the corporation in the blockchain sector.
Now, an altogether more technical offshoot addresses what it describes as a lack of platform offering “requisite controls and mechanisms” to safeguard scientific findings.
The patent application reads ” currently there are limited platforms that allow for sharing information about scientific research and showing transparent data collection and analysis steps. It further says that there are few options for ensuring that data will be resistant to modifications as the platforms that exists, lacks requisite controls and mechanisms to allow for trustworthy data.
More broadly, with the advent of this technology, the scientific sector is going to be benefitted in multiple ways.
Various attempts have already targeted some aspects of the field. As reported earlier this year, for both pharmaceuticals and genomics research data, Cointelegraph is using industry-specific blockchain tools.